| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.10▲ | 3.09▲ | 3.08▲ | 3.06▲ | 2.92▲ |
| MA10 | 3.10▲ | 3.06▲ | 3.07▲ | 3.08▲ | 3.10▲ |
| MA20 | 3.09▲ | 3.07▲ | 3.09▲ | 2.94▲ | 4.21▼ |
| MA50 | 3.06▲ | 3.05▲ | 3.05▲ | 3.20▼ | 3.37▼ |
| MA100 | 3.07▲ | 3.06▲ | 3.01▲ | 4.36▼ | 2.84▲ |
| MA200 | 3.09▲ | 2.99▲ | 2.96▲ | 3.80▼ | 2.27▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.005▲ | 0.001▲ | 0.050▲ | -0.226▼ |
| RSI | 61.234▲ | 58.672▲ | 56.298▲ | 50.162▲ | 42.543▼ |
| STOCH | 45.556 | 52.897 | 48.504 | 46.725 | 13.402▼ |
| WILL %R | -30.000 | -23.077▲ | -42.857 | -34.921 | -89.159▼ |
| CCI | 103.704▲ | 175.402▲ | 70.202 | 51.402 | -51.221 |
|
Friday, March 06, 2026 09:04 AM
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/03/26 | 3.02 | 3.155 | 3.00 | 3.10 | 350,338 |
| 05/03/26 | 3.11 | 3.21 | 3.00 | 3.03 | 341,600 |
| 04/03/26 | 3.01 | 3.205 | 2.9591 | 3.11 | 401,287 |
| 03/03/26 | 3.03 | 3.06 | 2.86 | 2.98 | 375,783 |
| 02/03/26 | 2.98 | 3.10 | 2.872 | 3.06 | 377,692 |
| 27/02/26 | 3.11 | 3.17 | 2.93 | 2.98 | 530,500 |
| 26/02/26 | 3.22 | 3.22 | 2.99 | 3.14 | 301,314 |
| 25/02/26 | 3.18 | 3.32 | 3.16 | 3.22 | 152,000 |
| 24/02/26 | 3.04 | 3.18 | 2.99 | 3.16 | 215,389 |
| 23/02/26 | 2.97 | 3.08 | 2.91 | 3.03 | 107,800 |
|
|
||||
|
|
||||
|
|